Restoration of Meibomian Gland Functionality with Novel Mesenchymal Stem Cell-Derived Product “Derived-Multiple Allogeneic Proteins Paracrine Signaling (d-MAPPS)”: A Case Report

Publicado en línea: 20 jun 2023

Páginas: 169 - 174

Recibido: 24 feb 2020

Aceptado: 17 mar 2020

DOI: https://doi.org/10.2478/sjecr-2020-0059

Palabras clave

Meibomian gland dysfunction, therapy, mesenchymal stem cells, d-MAPPS

© 2023 Carl Randall Harrell et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.